Direct action of this drug
•decreases maximal rate of phase 0
•decreases slope of phase 4
•decreases spontaneous depolarization of Purkinje fibers, but spares the automaticity of the SA node (controls automaticity)
•prolongs the effective refractory period of atrial and ventricular myocardium without affecting the normal pacemaker cells (controls atrial fibrillation).
•For atrial fibrillation in dogs and horses; also for ventricular premature beat